United States - English - NLM (National Library of Medicine)

medvantx, inc. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 100 mg - major depressive disorder sertraline hydrochloride tablets usp are indicated for the treatment of major depressive disorder in adults. the efficacy of sertraline hydrochloride tablets usp in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical trials under clinical pharmacology). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the antidepressant

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - sertraline hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - sertraline hydrochloride -

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - sertraline hydrochloride - film coated tablet - 50 milligram - sertraline

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - sertraline hydrochloride - film coated tablet - 100 milligram - sertraline

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - sertraline hydrochloride, quantity: 112 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; hyprolose; sodium starch glycollate; calcium hydrogen phosphate; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; macrogol 400 - adults: sertraline-lapl tablets are indicated for the treatment of major depression. sertraline-lapl tablets are indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - sertraline hydrochloride, quantity: 56 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; magnesium stearate; sodium starch glycollate; calcium hydrogen phosphate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; indigo carmine aluminium lake - adults: sertraline-lapl tablets are indicated for the treatment of major depression. sertraline-lapl tablets are indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - sertraline hydrochloride - film-coated tablet - 50 milligram(s) - selective serotonin reuptake inhibitors; sertraline

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - sertraline hydrochloride - film-coated tablet - 100 milligram(s) - selective serotonin reuptake inhibitors; sertraline

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - sertraline hydrochloride - oral tablet - 50mg